DC
ANIP icon

Deere & Company’s ANI Pharmaceuticals ANIP Stock Holding History

Deere & Company’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-19,044
Closed -$1.26M – 65
2016
Q3 		$1.26M Sell
19,044
-4,340
-19% -$271K 0.07% 328
2016
Q2 		$1.3M Buy
+23,384
New +$1.14M 0.07% 269
2016
Q1 		– Sell
-43,448
Closed -$1.96M – 997
2015
Q4 		$1.96M Buy
+43,448
New +$1.87M 0.11% 177
2015
Q2 		– Sell
-38,443
Closed -$2.4M – 991
2015
Q1 		$2.4M Buy
38,443
+29,971
+354% +$1.82M 0.13% 166
2014
Q4 		$478K Buy
+8,472
New +$374K 0.03% 638

Other funds holding ANIP

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Deere & Company's ANIP Position: Q4 2016 in Review

Deere & Company sold out of ANI Pharmaceuticals (ANIP) in Q4 2016, closing a stake of 19,044 shares — an estimated $1.26M sold.

Deere & Company first reported a position in ANIP in Q4 2014 and held it in 5 quarters. The position peaked at $2.4M in Q1 2015. 157 funds tracked by Wall St. Rank hold ANIP as of Q4 2016.

  • Deere & Company reported no remaining ANI Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Deere & Company sold 19,044 ANI Pharmaceuticals shares in Q4 2016, an estimated $1.26M.
  • Deere & Company first reported a position in ANI Pharmaceuticals in Q4 2014 and held it in 5 quarters.
  • Deere & Company's ANI Pharmaceuticals position peaked at $2.4M in Q1 2015.
  • 157 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.